← Open Payments lookup

LOAN HO: Open Payments

NPI 1568895274 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,063 in 86 payments from 12 companies in 2025. Trend: 2023 $1,899 · 2024 $2,051 · 2025 $2,063

Food & beverage: $1,973Education: $90
CompanyPaymentsAmount
Janssen Biotech, Inc.16$500
Gilead Sciences, Inc.17$422
Madrigal Pharmaceuticals11$339
ABBVIE INC.13$264
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$165
Intercept Pharmaceuticals, Inc.5$93
Organon LLC4$84
Takeda Pharmaceuticals U.S.A., Inc.3$69
Becton, Dickinson and Company1$59
Ipsen Biopharmaceuticals, Inc1$25

Products named: TREMFYA, REZDIFFRA, XIFAXAN, SKYRIZI, Livdelzi, OCALIVA, HADLIMA, RINVOQ.

Industry payments across TX — which companies pay providers there.